Patient Priorities Care for Breast Cancer Survivors

Overseen by Dana E. Giza, MD

Age: 65+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: The University of Texas Health Science Center, Houston

No Placebo Group

Trial Summary

What is the purpose of this trial?

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.

Research Team

Dana E. Giza, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for older adults who have survived breast cancer. Participants should be interested in a care approach that focuses on their personal health priorities. Specific eligibility details are not provided, so it's best to contact the study team for more information.

Inclusion Criteria

I have 3 or more health conditions, take 10 or more medications, or have had multiple hospital visits.

Able to provide consent

Able to write and speak English

Exclusion Criteria

I am currently undergoing treatment for cancer.

Treatment Details

Interventions

• Adapted Patient Priorities Care (PPC) approach (Behavioral Intervention)

Trial Overview The study is testing an adapted Patient Priorities Care (PPC) framework against usual care practices. It aims to tailor survivorship care based on feedback from patients and physicians, focusing on what matters most to the patient.

Participant Groups

Group I: Adapted Patient Priorities Care (PPC) approach plus Usual Care Experimental Treatment 2 Interventions

Group II: Usual Care Active Control 1 Intervention

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials

974

Recruited

361,000+

Dr. LaTanya Love

The University of Texas Health Science Center, Houston

Interim President

MD from UT Medical Branch in Galveston

Dr. Jagat Narula

The University of Texas Health Science Center, Houston

Chief Academic Officer since 2023

MD, PhD

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials

394

Recruited

404,000+

Dominique C. Pichard

National Center for Advancing Translational Sciences (NCATS)

Chief Medical Officer since 2023

MD

Joni L. Rutter

National Center for Advancing Translational Sciences (NCATS)

Chief Executive Officer since 2022

PhD in Pharmacology